Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Coch

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Neuroimage. Clinical|November 18, 2019
Interferon-beta-induced changes in neuroimaging phenotypes of appetitive motivation and reactivity to emotional salienceChristoph Coch, Roberto Viviani, Jörg Breitfeld, et al.
Journal for Immunotherapy of Cancer|June 13, 2022
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicityBeatrice Thier, Fang Zhao, Simone Stupia, et al.
Journal of Leukocyte Biology|July 22, 2009
Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNAChristoph Coch, Nicolas Busch, Vera Wimmenauer, et al.
Journal of Neuro-Oncology|December 9, 2021
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannomaJohannes Wach, Ági Güresir, Valeri Borger, et al.
Frontiers in Pharmacology|February 13, 2020
Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With <i>CYP2C9</i> and <i>VKORC1</i> PolymorphismsKatharina Luise Schneider, Melanie Kunst, Ann-Kristin Leuchs, et al.
Viruses|July 27, 2022
Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus InfectionLara S U Schwab, Fernando Villalón-Letelier, Melkamu B Tessema, et al.
International Journal of Molecular Sciences|October 2, 2020
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic SignatureTheophilos Tzaridis, Katrin S Reiners, Johannes Weller, et al.
International Journal of Molecular Sciences|September 10, 2021
Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic ApplicationsTheophilos Tzaridis, Daniel Bachurski, Shu Liu, et al.
Journal of Virology|August 2, 2022
Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of FerretsLara S U Schwab, Sarah L Londrigan, Andrew G Brooks, et al.
Antiviral Therapy|August 6, 2011
Delivery with polycations extends the immunostimulant Ribomunyl into a potent antiviral Toll-like receptor 7/8 agonistStephan Herberhold, Christoph Coch, Thomas Zillinger, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Neuroimage. Clinical|November 18, 2019
Interferon-beta-induced changes in neuroimaging phenotypes of appetitive motivation and reactivity to emotional salienceChristoph Coch, Roberto Viviani, Jörg Breitfeld, et al.
Journal for Immunotherapy of Cancer|June 13, 2022
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicityBeatrice Thier, Fang Zhao, Simone Stupia, et al.
Journal of Leukocyte Biology|July 22, 2009
Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNAChristoph Coch, Nicolas Busch, Vera Wimmenauer, et al.
Journal of Neuro-Oncology|December 9, 2021
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannomaJohannes Wach, Ági Güresir, Valeri Borger, et al.
Frontiers in Pharmacology|February 13, 2020
Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With <i>CYP2C9</i> and <i>VKORC1</i> PolymorphismsKatharina Luise Schneider, Melanie Kunst, Ann-Kristin Leuchs, et al.
Viruses|July 27, 2022
Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus InfectionLara S U Schwab, Fernando Villalón-Letelier, Melkamu B Tessema, et al.
International Journal of Molecular Sciences|October 2, 2020
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic SignatureTheophilos Tzaridis, Katrin S Reiners, Johannes Weller, et al.
International Journal of Molecular Sciences|September 10, 2021
Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic ApplicationsTheophilos Tzaridis, Daniel Bachurski, Shu Liu, et al.
Journal of Virology|August 2, 2022
Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of FerretsLara S U Schwab, Sarah L Londrigan, Andrew G Brooks, et al.
Antiviral Therapy|August 6, 2011
Delivery with polycations extends the immunostimulant Ribomunyl into a potent antiviral Toll-like receptor 7/8 agonistStephan Herberhold, Christoph Coch, Thomas Zillinger, et al.
Pageof 7